Rabbit Anti-Human IgG, F(ab')₂ fragment specific; HRP conjugated

Shipped with Ice Packs
In Stock

Product Specs

Buffer
0.01M Sodium Phosphate, 0.25M NaCl, pH 7.6
Form
Liquid
Lead Time
We typically dispatch orders for Rabbit Anti-Human IgG, F(ab')₂ fragment specific; HRP conjugated within 1-3 business days of receipt. Delivery times may vary depending on the shipping method and destination. Please consult your local distributor for specific delivery details.

Q&A

Basic Research Questions

  • What is the F(ab')₂ fragment of human IgG and why target it specifically?

    The F(ab')₂ fragment is a proteolytic fragment of immunoglobulin G (IgG) obtained through limited digestion with pepsin enzyme under controlled conditions of temperature, time, and pH . This fragment contains two antigen-binding sites but lacks the Fc portion of IgG.

    Targeting F(ab')₂ specifically offers several research advantages:

    • F(ab')₂ molecules lack the Fc portion, so receptors that bind human IgG Fc will not bind human IgG F(ab')₂ molecules

    • This specificity helps avoid unwanted interactions with Fc receptors in experimental systems

    • It reduces background in immunoassays where Fc-mediated binding might interfere

    • It enables investigation of specific antibody-antigen interactions without Fc-mediated effects

    These advantages make F(ab')₂-specific antibodies particularly valuable in applications requiring high specificity and minimal background.

  • How is Rabbit Anti-Human IgG F(ab')₂ produced and purified?

    Production of Rabbit Anti-Human IgG F(ab')₂ antibodies follows a multi-step process:

    1. Immunization: Rabbits are immunized with human IgG F(ab')₂ fragments through repeated injections to elicit a strong immune response

    2. Serum collection: After sufficient antibody titer is confirmed (e.g., by ELISA showing high absorbance at dilutions as high as 1/128000), serum is collected from the hyperimmunized rabbits

    3. Antibody purification: IgG antibodies are isolated using:

      • Ion-Exchange Chromatography (IEC)

      • Immunoaffinity chromatography using human IgG coupled to agarose beads

      • Additional solid-phase adsorption steps to remove unwanted reactivities

    4. Quality assessment: Purified antibodies undergo quality control:

      • SDS-PAGE to confirm purity (showing a single band at ~150 kDa under non-reducing conditions and two bands at ~50 kDa and ~25 kDa under reducing conditions)

      • Immunoelectrophoresis and ELISA to verify binding specificity

    5. HRP conjugation: For HRP-conjugated versions, the periodate method is often employed to attach the horseradish peroxidase enzyme to the purified antibody

    This rigorous production process ensures high specificity and minimal cross-reactivity in the final product.

  • What are the common applications for Rabbit Anti-Human IgG F(ab')₂ HRP-conjugated antibodies?

    Rabbit Anti-Human IgG F(ab')₂ HRP-conjugated antibodies are versatile reagents employed across numerous immunodetection techniques:

    ApplicationDetails
    ELISAParticularly valuable in sandwich ELISAs and indirect detection systems
    Western BlotUsed for detecting human antibodies in protein analysis with recommended dilutions of 1:3,000-1:15,000
    ImmunohistochemistryApplicable to both frozen and paraffin-embedded tissue sections
    Dot BlotUseful for rapid screening of samples for human antibodies
    ImmunocytochemistryAllows cellular localization of human antibodies
    Flow CytometryWhen appropriately formulated and used with suitable substrates

    The broad utility of these antibodies stems from their high specificity for the F(ab')₂ region of human IgG and the versatility of the HRP conjugate, which enables sensitive colorimetric or chemiluminescent detection across multiple platforms .

  • What dilution ranges are recommended for Rabbit Anti-Human IgG F(ab')₂ HRP in different applications?

    Optimal dilution ranges vary by application and specific antibody preparation:

    ApplicationRecommended Dilution RangeSource
    ELISA1:350,000
    ELISA1:5,000 - 1:20,000
    Western Blot1:3,000 - 1:15,000
    Western Blot1:5,000 - 1:20,000
    Immunohistochemistry1:1,000 - 1:5,000
    Immunohistochemistry1:500 - 1:1,000

    These ranges serve as starting points, and researchers should:

    • Perform titration experiments to determine optimal concentration for specific experimental conditions

    • Consider signal-to-noise ratio when selecting dilutions

    • Adjust dilutions based on substrate sensitivity and detection system

    • Validate new lots of antibody as dilution optima may vary between production batches

    Using too concentrated antibody can increase background, while excessive dilution may result in insufficient signal .

  • How should Rabbit Anti-Human IgG F(ab')₂ HRP conjugated antibodies be stored for optimal stability?

    Proper storage is crucial for maintaining antibody functionality over time:

    Primary storage recommendations:

    • Temperature: 2-8°C (refrigerated) for most formulations

    • Some products may be stored at -20°C according to manufacturer specifications

    • Avoid freeze/thaw cycles as they may denature the antibody

    Formulation considerations:

    • Many products are supplied in 50% Glycerol/50% Phosphate buffered saline, pH 7.4 to enhance stability

    • Preservatives like 0.01% Thiomersal or 0.05% sodium azide are typically included to prevent microbial growth

    • For HRP-conjugated antibodies, protection from light is recommended to preserve enzyme activity

    Stability factors:

    • Working dilutions should be prepared fresh for each experiment

    • Aliquoting stock solution prevents repeated freeze-thaw cycles

    • Expiration dates typically indicate six months from reconstitution

    Following manufacturer-specific guidelines is essential as formulations may vary between suppliers.

  • What cross-reactivity concerns exist with Rabbit Anti-Human IgG F(ab')₂ antibodies?

    Understanding potential cross-reactivity is essential for experimental design and data interpretation:

    Common cross-reactivity patterns:

    • Cross-reactivity with light chains of human IgM and IgA due to shared light chain structures

    • Possible reactivity with immunoglobulins from other species unless specifically adsorbed

    Pre-adsorbed preparations:

    • Many commercial antibodies are pre-adsorbed against potential cross-reactive species:

      • "Minimal crossreactivity against MOUSE Serum Proteins"

      • "Assay by immunoelectrophoresis resulted in a single precipitin arc against anti-Rabbit Serum, Human IgG, Human IgG F(ab')₂ and Human Serum. No reaction was observed against Human IgG F(c) or Mouse Serum Proteins."

    Validation methods:

    • Immunoelectrophoresis and ELISA are commonly used to assess specificity

    • "By immunoelectrophoresis and ELISA this antibody reacts specifically with Human IgG F(ab')₂. No antibody was detected against non-immunoglobulin serum proteins."

    Experimental precautions:

    • Include appropriate controls to identify potential cross-reactivity

    • Pre-clear samples when working with complex biological materials

    • Select antibodies adsorbed against species relevant to your experimental system

Advanced Research Questions

  • How does the binding affinity of Rabbit Anti-Human IgG F(ab')₂ compare to other secondary antibodies in multiplex assays?

    The binding characteristics of anti-F(ab')₂ antibodies have significant implications for multiplex assay performance:

    Affinity measurements:

    • Studies of anti-F(ab')₂ antibodies have reported affinity constants (Ka) in the range of 0.79 × 10^7 M^-1 to 2.78 × 10^7 M^-1

    • These values are "relatively high compared with previously described intact anti-IgG autoantibodies of rheumatoid patients"

    Performance in multiplex context:

    • Higher affinity generally correlates with:

      • Greater sensitivity for detecting low abundance targets

      • Improved signal-to-noise ratios

      • Enhanced stability of antibody-antigen complexes during washing steps

    Competitive binding studies:

    • Research has shown that recombinant anti-F(ab')₂ antibody fragments can effectively inhibit serum anti-F(ab')₂ activity in competitive inhibition ELISAs

    • This competitive binding capability indicates shared epitope recognition and comparable binding strength

    The high affinity and epitope specificity of Rabbit Anti-Human IgG F(ab')₂ antibodies make them particularly valuable in multiplex assays where distinguishing between closely related targets is essential.

  • What strategies can minimize background when using Rabbit Anti-Human IgG F(ab')₂ HRP in complex biological samples?

    Reducing background is critical for accurate detection in complex samples:

    Antibody selection:

    • Use pre-adsorbed antibody preparations to minimize cross-reactivity with non-target species

    • Select F(ab')₂ fragments of secondary antibodies to eliminate potential Fc-mediated interactions

    Blocking optimization:

    • Employ species-appropriate blocking reagents that won't cross-react with detection antibodies

    • Consider specialized blockers for tissues with high endogenous biotin or peroxidase activity

    Sample preparation:

    • Pre-clear complex biological samples with irrelevant antibodies or protein A/G

    • For tissue sections, block endogenous peroxidase activity before antibody application

    Assay optimization:

    • Titrate antibody concentration to determine optimal signal-to-noise ratio

    • Increase wash stringency (duration, detergent concentration) to reduce non-specific binding

    • Use diluents containing carrier proteins from species unrelated to the detection system

    Controls:

    • Include isotype controls to assess non-specific binding

    • Run secondary-only controls to evaluate direct binding to sample components

    • Use competitive inhibition controls to confirm signal specificity

    These strategies must be systematically evaluated and combined for optimal results with specific sample types.

  • How can Rabbit Anti-Human IgG F(ab')₂ be validated for specificity in transgenic models expressing human antibodies?

    Validating antibody specificity in transgenic models requires comprehensive analytical approaches:

    Analytical techniques from transgenic rabbit studies:

    • ELISA analysis can distinguish different antibody populations:

      • "The three transgenic rabbits used for immunization had robust human Ig serum levels irrespective of whether they were hemizygous or homozygous for the human Ig transgenes"

      • "Clearly, no rabbit IgM could be detected in the sera, whereas robust human IgM, IgG and human kappa levels were detected in all animals"

    • Flow cytometry (FACS) analysis using specific detection antibodies:

      • "The presence of the fully human IgG1 on the cell surface of a few transgenic B cells was proved by a detection antibody that specifically binds to human IgG1 Fc, but not to rabbit IgG Fc"

    Validation strategy for transgenic models:

    1. Comparative testing:

      • Side-by-side testing with non-transgenic controls

      • Analysis of mixed samples with defined ratios of human and host antibodies

    2. Competitive binding assays:

      • Pre-incubation with unlabeled anti-F(ab')₂ antibodies should block specific binding

      • Dose-dependent inhibition confirms specificity

    3. Cross-adsorption studies:

      • Pre-adsorbing antibodies against host species proteins should not affect binding to human IgG

    4. Molecular validation:

      • Sequence analysis to confirm the identity of detected antibodies as human, host, or chimeric

    This multi-faceted approach provides robust validation essential for accurately interpreting results from transgenic model systems.

  • What are the advantages of using F(ab')₂ fragment-specific antibodies over whole IgG-specific antibodies in certain experimental designs?

    F(ab')₂ fragment-specific antibodies offer distinct advantages in particular research contexts:

    Elimination of Fc-mediated effects:

    • F(ab')₂-specific antibodies don't interact with Fc receptors, preventing Fc-mediated binding that could confound results

    • "F(ab')₂ molecules lack the Fc portion of IgG and therefore receptors that bind human IgG F(c) will not bind human IgG F(ab')₂ molecules"

    Immunoregulatory research applications:

    • "Recent studies revealed an immunoregulatory role of natural IgG-anti-F(ab')₂ antibodies in both healthy individuals and patients with certain diseases"

    • Involved in various disease mechanisms: "IgG-anti-F(ab')₂ antibodies also were shown to play a role in kidney graft rejection, the pathogenesis of AIDS, and systemic lupus erythematosus"

    Therapeutic antibody development:

    • Allow specific detection of therapeutic antibody fragments

    • Enable monitoring of antibody processing in vivo

    Technical advantages:

    • Reduced background in assays where Fc binding contributes to non-specific signal

    • Improved penetration into tissues due to smaller size

    • More precise epitope mapping and characterization

    Disease-specific applications:

    • In autoimmune conditions: "In cold agglutination, an autoimmune disease caused by anti-erythrocyte autoantibodies, we found a striking inverse correlation between IgG-anti-F(ab')₂ and autoantibody production"

    • Potential "immunoregulatory role in both healthy individuals and patients with certain diseases"

    These advantages make F(ab')₂-specific antibodies particularly valuable for studies focused on antibody-antigen interactions independent of Fc-mediated functions.

  • How do different conjugation methods affect the sensitivity and stability of Rabbit Anti-Human IgG F(ab')₂ HRP antibodies?

    Conjugation chemistry significantly impacts antibody performance characteristics:

    Common conjugation methods:

    • Periodate method: Used for attaching HRP to pepsin-digested F(ab')₂ fragments

    • Additional methods include glutaraldehyde, maleimide, and NHS-ester based approaches

    Impact on antibody characteristics:

    ParameterEffects of Conjugation Method
    Enzyme activityDifferent methods preserve varying degrees of HRP catalytic activity
    Antibody bindingSite-specific methods help preserve antigen-binding regions
    StabilityGlycerol formulations (e.g., "50% Glycerol/50% Phosphate buffered saline" ) enhance conjugate stability
    BackgroundExcessive conjugation can increase non-specific binding
    SensitivityOptimal enzyme:antibody ratio provides maximal signal with minimal background

    Optimization considerations:

    • Conjugate performance should be validated in the specific application context

    • Storage conditions significantly affect conjugate shelf-life

    • Buffer composition influences both stability and background signal

    • Signal detection systems must be matched to conjugate performance characteristics

    The specific conjugation method should be selected based on the requirements of the intended application, with particular attention to stability needs and detection sensitivity requirements.

  • What considerations are important when using Rabbit Anti-Human IgG F(ab')₂ HRP in flow cytometry versus immunohistochemistry?

    Application-specific optimizations are critical for successful results across different techniques:

    Flow Cytometry Considerations:

    • Conjugate selection:

      • For direct detection, fluorophore conjugates like PE are often preferred over HRP

      • "Goat F(ab')₂ Anti-Rabbit IgG(H+L)-PE antibody with minimal reactivity to mouse and human proteins for use in flow cytometry assays"

    • Protocol optimization:

      • Cell fixation methods must preserve epitope recognition

      • Titration to determine optimal concentration is essential

      • Controls for autofluorescence and non-specific binding are critical

    • Special requirements:

      • Surface vs. intracellular staining protocols differ significantly

      • Pre-adsorbed antibodies minimize background with mixed species samples

    Immunohistochemistry Considerations:

    • Detection system:

      • HRP conjugates work well with appropriate substrates like DAB

      • Signal amplification systems may be needed for low-abundance targets

    • Tissue-specific factors:

      • Fixation methods significantly impact epitope accessibility

      • Antigen retrieval may be necessary for formalin-fixed tissues

      • Endogenous peroxidase must be blocked to prevent false positives

    • Concentration differences:

      • Generally requires higher concentrations than flow cytometry

      • Typical dilutions range from 1:500-1:5,000

    Common factors across applications:

    • Sample-specific validation is essential regardless of technique

    • Pre-adsorption requirements depend on sample species composition

    • Storage conditions affect performance in all applications

    Optimizing these application-specific factors ensures reliable and reproducible results in both flow cytometry and immunohistochemistry experiments.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2024 Thebiotek. All Rights Reserved.